These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9123408)

  • 21. Orthotopic liver transplantation can protect small bowel free grafts from rejection.
    Lee SK; Perez-Atayde A; Vacanti JP; Lund DP
    Transplant Proc; 1994 Aug; 26(4):2300-1. PubMed ID: 8066757
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of thromboxane synthetase inhibitors on cyclical reduction of coronary blood flow in dogs.
    Uchida Y; Murao S
    Jpn Heart J; 1981 Nov; 22(6):971-5. PubMed ID: 7040725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute rejection of rat renal allografts is influenced by the presence of a native kidney.
    Grau V; Herbst B; Steiniger B
    Transplant Proc; 1997 May; 29(3):1723. PubMed ID: 9142247
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of thromboxane synthetase inhibitor on non-heart-beating donors in rat orthotopic liver transplantation.
    Soejima Y; Yanaga K; Nisizaki T; Yoshizumi T; Uchiyama H; Sugimachi K
    Surgery; 1998 Jan; 123(1):67-72. PubMed ID: 9457225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis in combined liver/small bowel transplantation.
    Meyer D; Baumgardt S; Löffeler S; Gassel HJ; Czub S; Ulrichs K; Thiede A
    Transplant Proc; 1998 Sep; 30(6):2588. PubMed ID: 9745502
    [No Abstract]   [Full Text] [Related]  

  • 26. Estimation of graft arteriosclerosis after allogeneic fresh and cryopreserved aortic transplantation in the rat.
    Gabriel M; Fändrich F
    Transplant Proc; 2002 Mar; 34(2):711-2. PubMed ID: 12009674
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor].
    Yasuda K; Matsui Y; Goda T; Sakuma M; Go K
    Nihon Rinsho; 1991 Sep; 49(9):2149-54. PubMed ID: 1960880
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum and bile individual bile acid changes as a noninvasive marker of small bowel allograft rejection in rats.
    Miyagi K; Kiyochi H; Honda K; Kobayashi K
    Transplant Proc; 2000 Sep; 32(6):1265-6. PubMed ID: 10995940
    [No Abstract]   [Full Text] [Related]  

  • 29. Mucosal perfusion in the rat intestinal allograft during acute rejection.
    Tabasco-Minguillán J; Cicalese L; Weber K; Lee RG; Rakela J
    Transplant Proc; 1996 Oct; 28(5):2578-80. PubMed ID: 8907961
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolongation of experimental cardiac allograft survival with thromboxane-related drugs.
    Foegh ML; Khirabadi B; Ramwell PW
    Transplantation; 1985 Aug; 40(2):124-5. PubMed ID: 3161224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase of interleukin-6 in the intestinal mucosa and muscularis following chronic rejection after small bowel transplantation.
    Walgenbach KJ; Heeckt PF; Kalff JC; Stanson J; Whiteside TL; Hirner A; Bauer AJ
    Transplant Proc; 1998 Sep; 30(6):2600. PubMed ID: 9745508
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathological changes following intestinal transplantation in the rat.
    Garcia B; Zhong R; Wijsman J; Wang P; Chen H; Sutherland F; Duff J; Grant D
    Transplant Proc; 1990 Dec; 22(6):2469-70. PubMed ID: 2264112
    [No Abstract]   [Full Text] [Related]  

  • 33. Differentiation between preservation reperfusion injury and acute rejection after small bowel transplantation.
    Mueller AR; Platz KP; Heckert C; Häusler M; Schuppan D; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Sep; 30(6):2657-9. PubMed ID: 9745536
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
    Stoltenberg R; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplant Proc; 1994 Oct; 26(5):2569-70. PubMed ID: 7940794
    [No Abstract]   [Full Text] [Related]  

  • 35. Loss of intestinal integrity following small bowel transplant rejection in the rat.
    Teitelbaum DH; Sonnino RE; Harmel RP
    Transplant Proc; 1996 Oct; 28(5):2547-8. PubMed ID: 8907944
    [No Abstract]   [Full Text] [Related]  

  • 36. Endogenous biosynthesis of prostaglandin I2 and thromboxane A2 by isolated rat dental pulp.
    Hirafuji M; Ogura Y
    Biochem Pharmacol; 1983 Oct; 32(19):2983-5. PubMed ID: 6354192
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenovirus-mediated CD40Ig expression attenuates chronic vascular rejection lesions in an aorta allotransplantation model.
    Mathieu P; Guillot C; Gerdes C; Buzelin F; Lowenstein P; Castro M; Soulillou JP; Anegon I
    Transplant Proc; 2002 May; 34(3):743-4. PubMed ID: 12034168
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigations of the immunoprotective role of the liver after allogeneic orthotopic combined liver-small-bowel transplantation in the rat.
    Gassel HJ; Timmermann W; Meyer D; Gassel AM; Thiede A
    Transplant Proc; 1997; 29(1-2):693-4. PubMed ID: 9123484
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 40. Extracellular matrix: an early target of preservation/reperfusion injury and acute rejection after small bowel transplantation.
    Mueller AR; Platz KP; Heckert C; Häusler M; Guckelberger O; Schuppan D; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Sep; 30(6):2569-71. PubMed ID: 9745492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.